Risk factors for COVID-19 associated mucormycosis in India: A case control study.

Atul K PatelHarsh BakshiKahaan ShahSaloni PatelTushar PatelKamlesh PatelKetan K Patel

Published in: Medical mycology (2022)

This study revealed new-onset diabetes, pre-existing diabetes, corticosteroid therapy, and home isolation as risk factors for COVID-19-associated mucormycosis. Avoiding the use of corticosteroids in non-severe COVID-19 disease coupled with proper blood sugar monitoring and control will help to reduce the CAM burden.

Keyphrases

coronavirus disease
sars cov
type diabetes
cardiovascular disease
glycemic control
healthcare
respiratory syndrome coronavirus
single cell
risk factors
stem cells
adipose tissue